Vericel Corp

Common Name

Vericel

Country

United States

Sector

Healthcare

Industry

Biotechnology

Employees

357

Ticker

VCEL

Exchange

NASDAQ/NMS

Website

vcel.com

Description

Vericel Corporation is a biopharmaceutical company focused on the development and commercialization of innovative cellular therapies for patients with severe diseases and conditions. The company's pri... Show more

Financial Statements of Vericel

Below are the financial statements of Vericel, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Income Statement (as reported) Balance Sheet (as reported)

All figures in thousands of USD	2024	2023
Current assets	—	—
Cash and cash equivalents	74,520^a	69,088^a
Restricted cash	10,529^a	17,778^a
Short-term investments	41,693^a	40,469^a
Accounts receivable, net	61,375^a	58,356^a
Inventory	17,373^a	13,087^a
Other current assets	7,287^a	6,853^a
Total current assets	212,777^a	205,631^a
Assets	—	—
Property and equipment, net	103,161^a	41,635^a
Intangible assets, net	6,250^a	6,875^a
Right-of-use assets	70,098^a	73,462^a
Long-term investments	39,880^a	25,283^a
Other long-term assets	556^a	771^a
Total assets	432,722^a	353,657^a
Current liabilities	—	—
Accounts payable	23,848^a	22,347^a
Accrued expenses	17,065^a	17,215^a
Current portion of operating lease liabilities	9,257^a	6,187^a
Other current liabilities	116^a	0^a
Total current liabilities	50,286^a	45,749^a
Liabilities and shareholders’ equity	—	—
Operating lease liabilities	89,593^a	81,856^a
Other long-term liabilities	876^a	100^a
Total liabilities	140,755^a	127,705^a
Shareholders’ equity	—	—
Common stock, no par value	684,778^a	629,229^a
Accumulated other comprehensive loss	4^a	-100^a
Accumulated deficit	-392,815^a	-403,177^a
Total shareholders’ equity	291,967^a	225,952^a
Total liabilities and shareholders’ equity	432,722^a	353,657^a

Verified Sources Behind Vericel’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Vericel’s data sources below and access millions more through our Disclosure Search.

a. Vericel's 10-K 2024

Trace every data point back to Vericel’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

Vericel Corp

Financial Statements of Vericel

Verified Sources Behind Vericel’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

SpringWorks Therapeutics Inc

Iovance Biotherapeutics Inc

BridgeBio Pharma Inc

Ultragenyx Pharmaceutical Inc

Cytokinetics Inc

Crinetics Pharmaceuticals Inc